Primary Cauda Equina Lymphoma Treated with CNS-Centric Approach: A Case Report and Literature Review

References

• Grisariu S, Avni B, Batchelor TT, et al. Neurolymphomatosis: an international primary CNS lymphoma collaborative group report. Blood. 2010;115(24):5005–5011.
   PubMed Web of Science ®Google Scholar
• Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH. Neurolymphomatosis. Neuro Oncol. 2003;5(2):104–115. doi:10.1215/15228517-5-2-104
   Web of Science ®Google Scholar
• Novo M, Nowakowski G, Micallef I, Ristow K, Habermann T, Johnston P. Clinical features, treatment and outcome of neurolymphomatosis: single institution experience. Age. 2019;60:37–83.
   Google Scholar
• Ferreri AJ, Cwynarski K, Pulczynski E, et al. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) Phase 2 trial. Lancet Haematol. 2016;3(5):e217–e227. doi:10.1016/S2352-3026(16)00036-3
   PubMed Web of Science ®Google Scholar
• Keddie S, Nagendran A, Cox T, et al. Peripheral nerve neurolymphomatosis: clinical features, treatment, and outcomes. Muscle Nerve. 2020;62(5):617–625. doi:10.1002/mus.27045
   Web of Science ®Google Scholar
• Li V, Jaunmuktane Z, Cwynarski K, Carr A. Diagnostic delay in a case of T-cell neurolymphomatosis. BMJ Case Rep. 2019;12(12):e232538. doi:10.1136/bcr-2019-232538
   Google Scholar
• Grommes C, Pastore A, Gavrilovic I, et al. Single-Agent Ibrutinib in Recurrent/Refractory Central Nervous System Lymphoma. Washington, DC: American Society of Hematology; 2016.
   Google Scholar
• Grommes C, Younes A. Ibrutinib in PCNSL: the curious cases of clinical responses and aspergillosis. Cancer Cell. 2017;31(6):731–733. doi:10.1016/j.ccell.2017.05.004
   PubMed Web of Science ®Google Scholar
• Lionakis MS, Dunleavy K, Roschewski M, et al. Inhibition of B cell receptor signaling by ibrutinib in primary CNS lymphoma. Cancer Cell. 2017;31(6):833–843. e835. doi:10.1016/j.ccell.2017.04.012
   PubMed Web of Science ®Google Scholar
• Soussain C, Choquet S, Blonski M, et al. Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: final analysis of the Phase II ‘proof-of-concept’iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network. Eur J Cancer. 2019;117:121–130.
   PubMed Web of Science ®Google Scholar
• Wilson WH, Young RM, Schmitz R, et al. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. Nat Med. 2015;21(8):922–926. doi:10.1038/nm.3884
   PubMed Web of Science ®Google Scholar
• Beitzke M, Enzinger C, Beitzke D, Neureiter D, Ladurner G, Fazekas F. Primary leptomeningeal lymphoma of the cauda equina: a rare cause of radiculopathy. J Neurol. 2010;257(10):1734–1737. doi:10.1007/s00415-010-5574-8
   Web of Science ®Google Scholar
• Belcastro V, Bellcocchi S, Patriarca C, et al. Cauda equina syndrome due to large B-cell lymphoma: a case report. Neurol Sci. 2016;37(5):825–827. doi:10.1007/s10072-015-2470-0
   Web of Science ®Google Scholar
• Broen M, Draak T, Riedl RG, Weber WE. Diffuse large B-cell lymphoma of the cauda equina. Case Rep. 2014;2014:bcr2014205950.
   Google Scholar
• Cugati G, Singh M, Symss NP, Pande A, Vasudevan M, Ramamurthi R. Primary spinal intradural extramedullary lymphoma causing cauda equina syndrome. J Craniovertebr Junction Spine. 2012;3(2):58. doi:10.4103/0974-8237.116538
   Google Scholar
• Giobbia M, Carniato A, Scotton P, Vaglia A, Marchiori G. Primary EBV-associated cauda equina lymphoma. J Neurol. 1999;246(8):739–740. doi:10.1007/s004150050445
   Web of Science ®Google Scholar
• Iwasaki M, Hida K, Yano S, Aoyama T, Kaneko S, Iwasaki Y. Primary cauda equina lymphoma treated with high-dose methotrexate. Neurol Med Chir (Tokyo). 2012;52(9):679–683. doi:10.2176/nmc.52.679
   Web of Science ®Google Scholar
• Khong P, Pitham T, Owler B. Isolated neurolymphomatosis of the cauda equina and filum terminale: case report. Spine. 2008;33(21):E807–E811. doi:10.1097/BRS.0b013e31818441be
   Google Scholar
• Klein P, Zientek G, VandenBerg SR, Lothman LE. Primary CNS lymphoma: lymphomatous meningitis presenting as a cauda equina lesion in an AIDS patient. Can J Neurol Sci. 1990;17(3):329–331. doi:10.1017/S0317167100030687
   Web of Science ®Google Scholar
• Knopp EA, Chynn KY, Hughes J. Primary lymphoma of the cauda equina: myelographic, CT myelographic, and MR appearance. Am J Neuroradiol. 1994;15(6):1187–1189.
   Web of Science ®Google Scholar
• Kumar N, Dyck PJB. Hypertrophy of the nerve roots of the cauda equina as a paraneoplastic manifestation of lymphoma. Arch Neurol. 2005;62(11):1776. doi:10.1001/archneur.62.11.1776
   Google Scholar
• Mauney M, Sciotto CG. Primary malignant lymphoma of the cauda equina. Am J Surg Pathol. 1983;7(2):185–190. doi:10.1097/00000478-198303000-00009
   Web of Science ®Google Scholar
• Morita M, Osawa M, Naruse H, Nakamura H. Primary NK/T-cell lymphoma of the cauda equina: a case report and literature review. Spine. 2009;34(24):E882–E885. doi:10.1097/BRS.0b013e3181b29de6
   PubMedGoogle Scholar
• Nakashima H, Imagama S, Ito Z, et al. Primary cauda equina lymphoma: case report and literature review. Nagoya J Med Sci. 2014;76(3–4):349.
   Web of Science ®Google Scholar
• Nishida H, Hori M, Obara K. Primary B-cell lymphoma of the cauda equina, successfully treated with high-dose methotrexate plus high-dose cytarabine: a case report with MRI findings. Neurol Sci. 2012;33(2):403–407. doi:10.1007/s10072-011-0752-8
   Web of Science ®Google Scholar
• Ooi G, Peh W, Fung C. Magnetic resonance imaging of primary lymphoma of the cauda equina. Br J Radiol. 1996;69(827):1057–1060. doi:10.1259/0007-1285-69-827-1057
   Web of Science ®Google Scholar
• Sasaki R, Ohta Y, Yamada Y, et al. A case of neurolymphomatosis in the cauda equina diagnosed by an open biopsy. Intern Med. 2019;1018–1049.
   Web of Science ®Google Scholar
• Shin HK, Oh SK, Woo CG, Huh JR, Suh CW, Jeon SR. Cauda equina lymphoma mimicking non-neoplastic hypertrophic neuropathy of the cauda equina: a case report. Br J Neurosurg. 2016;30(6):678–680. doi:10.3109/02688697.2015.1111295
   PubMed Web of Science ®Google Scholar
• Suzuki K, Yasuda T, Hiraiwa T, Kanamori M, Kimura T, Kawaguchi Y. Primary cauda equina lymphoma diagnosed by nerve biopsy: a case report and literature review. Oncol Lett. 2018;16(1):623–631.
   Web of Science ®Google Scholar
• Tajima Y, Sudo K, Matumoto A. Malignant lymphoma originating in the cauda equina mimicking the inflammatory polyradiculoneuropathy. Intern Med. 2007;46(13):1029–1032. doi:10.2169/internalmedicine.46.0005
   Web of Science ®Google Scholar
• Teo MK, Mathieson C, Carruthers R, Stewart W, Alakandy L. Cauda equina lymphoma–a rare presentation of primary central nervous system lymphoma: case report and literature review. Br J Neurosurg. 2012;26(6):868–871. doi:10.3109/02688697.2012.697225
   PubMed Web of Science ®Google Scholar
• Toner GC, Holmes R, Sinclair RA, Tang S, Schwarz MA. Central nervous system lymphoma: primary lumbar nerve root infiltration. Acta Haematol. 1989;81(1):44–47. doi:10.1159/000205399
   Web of Science ®Google Scholar
• Wang G, Liu Y, He F. Primary lymphoma involving cranial nerves and cauda equina detected by 18F-FDG PET/CT and MRI. Nuklearmedizin. 2016;55(05):N46–N48. doi:10.1055/s-0037-1616497
   Google Scholar
• Zagami A, Granot R. Non-Hodgkin’s lymphoma involving the cauda equina and ocular cranial nerves: case reports and literature review. J Clin Neurosci. 2003;10(6):696–699. doi:10.1016/S0967-5868(03)00089-4
   Web of Science ®Google Scholar